Please try another search
Hexima Limited does not have significant operations. It focuses on exploration of transactions with third parties, which could enable the value of the company’s assets. Previously, the company was involved in the research and development of pezadeftide for the treatment of onychomycosis. Hexima Limited was incorporated in 1997 and is headquartered in Carlton, Australia.
Name | Age | Since | Title |
---|---|---|---|
Richard K. Scher | - | 2021 | Member of the Scientific Advisory Board |
Shinichi Watanabe | - | 2021 | Member of the Scientific Advisory Board |
Robert Rosen | - | 2021 | Member of the Scientific Advisory Board |
Boni Elizabeth Elewski | - | 2021 | Member of the Scientific Advisory Board |
Justin Yap | - | 2018 | Non-Executive Director |
Mark G. Lebwohl | - | - | Member of Scientific Advisory Board |
Warren S. Joseph | - | 2021 | Member of the Scientific Advisory Board |
Phoebe Rich | - | 2021 | Member of the Scientific Advisory Board |
Tracey C. Vlahovic | - | 2021 | Member of the Scientific Advisory Board |
Peter Foley | - | 2021 | Member of the Scientific Advisory Board |
Shari Lipner | - | 2021 | Member of the Scientific Advisory Board |
Geoffrey Paul Kempler | 69 | 2023 | MD & Chairman |
Phillip Hains | - | 2023 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review